WELLS FARGO & COMPANY/MN - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 111 filers reported holding AKERO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 8.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,306,751
+2.0%
45,606
-5.9%
0.00%0.0%
Q2 2023$2,262,177
+61.5%
48,451
+32.3%
0.00%
Q1 2023$1,400,966
+1307.0%
36,617
+1915.2%
0.00%
Q4 2022$99,571
-93.4%
1,817
-95.9%
0.00%
Q3 2022$1,506,000
+8758.8%
44,235
+2354.8%
0.00%
Q2 2022$17,000
-70.7%
1,802
-55.9%
0.00%
Q1 2022$58,000
-78.8%
4,088
-68.4%
0.00%
Q4 2021$274,000
+2390.9%
12,950
+2614.9%
0.00%
Q3 2021$11,000
+83.3%
477
+110.1%
0.00%
Q2 2021$6,000
-45.5%
227
-39.8%
0.00%
Q1 2021$11,000
-98.6%
377
-98.7%
0.00%
Q4 2020$774,000
+294.9%
30,022
+369.6%
0.00%
Q3 2020$196,000
-63.2%
6,393
-70.0%
0.00%
Q2 2020$532,000
+309.2%
21,334
+247.2%
0.00%
Q1 2020$130,000
+85.7%
6,145
+94.2%
0.00%
Q4 2019$70,000
+677.8%
3,164
+719.7%
0.00%
Q3 2019$9,0003860.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$125,180,17850.58%
COMMODORE CAPITAL LP 790,000$30,225,4004.60%
Redmile Group, LLC 2,044,389$78,218,3233.39%
SILVERARC CAPITAL MANAGEMENT, LLC 202,561$7,749,9843.20%
Ghost Tree Capital, LLC 275,000$10,522,0003.11%
Avidity Partners Management LP 2,447,000$93,622,2203.11%
Atlas Venture Life Science Advisors, LLC 594,251$22,736,0433.08%
Logos Global Management LP 400,000$15,304,0002.19%
Yiheng Capital Management, L.P. 1,125,791$43,072,7641.70%
Boxer Capital, LLC 831,495$31,8131.56%
View complete list of AKERO THERAPEUTICS INC shareholders